Th17 cells in autoimmune and infectious diseases

International Journal of Inflammation

Volumn 2014, Issue , 2014, Pages

  Zambrano Zaragoza, José Francisco ^a   Romo Martínez, Enrique Jhonatan ^b   Durán Avelar, Ma De Jesús ^a   García Magallanes, Noemí ^b   Vibanco Pérez, Norberto ^a  

^a UNIVERSIDAD AUTÓNOMA DE NAYARIT   (Mexico)

^b Master Program in Applied Sciences   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS B SURFACE ANTIGEN; HEPATITIS B VACCINE; INTERLEUKIN 13; INTERLEUKIN 17; INTERLEUKIN 17F; INTERLEUKIN 1BETA; INTERLEUKIN 21; INTERLEUKIN 22; INTERLEUKIN 23; INTERLEUKIN 6; PEGINTERFERON; POLYPEPTIDE ANTIBIOTIC AGENT; RETINOID RELATED ORPHAN RECEPTOR ALPHA; RIBAVIRIN; TRANSFORMING GROWTH FACTOR BETA;

ADAPTIVE IMMUNITY; ARTICLE; ATHEROSCLEROSIS; AUTOIMMUNE DISEASE; AUTOIMMUNITY; B LYMPHOCYTE; BACTERIAL INFECTION; CARDIOVASCULAR DISEASE; CAROTID ATHEROSCLEROSIS; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; CROHN DISEASE; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DISEASE SEVERITY; EPITHELIUM CELL; FIBROBLAST; GLIOMA; HASHIMOTO DISEASE; HEPATITIS B; HEPATITIS C; HOMEOSTASIS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; IMMUNOPATHOGENESIS; INFECTION; INFLAMMATION; INFLAMMATORY BOWEL DISEASE; INNATE IMMUNITY; INSULIN DEPENDENT DIABETES MELLITUS; KERATINOCYTE; LYMPHOCYTE DIFFERENTIATION; LYMPHOCYTE PROLIFERATION; LYMPHOCYTE SUBPOPULATION; MACROPHAGE; MEMORY T LYMPHOCYTE; MULTIPLE SCLEROSIS; MYCOSIS; NATURAL KILLER CELL; NONHUMAN; PLEIOTROPY; PRIORITY JOURNAL; PSORIASIS; REGULATORY T LYMPHOCYTE; RHEUMATOID ARTHRITIS; SPONDYLOARTHROPATHY; SYSTEMIC LUPUS ERYTHEMATOSUS; T LYMPHOCYTE; TH1 CELL; TH17 CELL; TH2 CELL; ULCERATIVE COLITIS; VITILIGO;

EID: 84922968180     PISSN: 20908040     EISSN: 20420099     Source Type: Journal    
DOI: 10.1155/2014/651503     Document Type: Article

References (150)

1. E. Bettelli, T. Korn, and V. K. Kuchroo, "Th17: the thirdmember of the effector T cell trilogy, "Current Opinion in Immunology, vol. 19, no. 6, pp. 652-657, 2007
2. R. Duhen, S. Glatigny, C.A. Arbelaez, T. C. Blair, M. Oukka, and E. Bettelli, "Cutting edge: the pathogenicity of IFN-xy-Producing Th17 cells is independent of T-bet, "Journal of Immunology, vol. 190, no. 9, pp. 4478-4482, 2013
3. A. Peck and E. D. Mellins, "Breaking old paradigms:Th17 cells in autoimmune arthritis, "Clinical Immunology, vol. 132, no. 3, pp. 295-304, 2009
4. M. Noack and P. Miossec, "Th17 and regulatory T cell balance in autoimmune and inflammatory diseases, "Autoimmunity Reviews, vol. 13, no. 6, pp. 668-677, 2014
5. X. Song and Y. Qian, "The activation and regulation of IL-17 receptor mediated signaling, "Cytokine, vol. 62, no. 2, pp. 175-182, 2013
6. H. Park, Z. Li, X. O. Yang et al., "A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17, "Nature Immunology, vol. 6, no. 11, pp. 1133-1141, 2005
7. T. Korn, E. Bettelli, M. Oukka, and V. K. Kuchroo, "IL-17 and Th17 cells, "Annual Review of Immunology, vol. 27, pp. 485-517, 2009
8. U. Holzer, K. Reinhardt, P. Lang, R. Handgretinger, and N. Fischer, "Influence of amutation in IFN-xy receptor 2 (IFNGR2) in human cells on the generation of Th17 cells in memory T cells, "Human Immunology, vol. 74, no. 6, pp. 693-700, 2013
9. C. Dong, "Genetic controls of th17 cell differentiation and plasticity, "Experimental and Molecular Medicine, vol. 43, no. 1, pp. 1-6, 2011
10. W. Jin and C. Dong, "IL-17 cytokines in immunity and inflammation, "EmergingMicrobes&Infections, vol. 2, article e60, 2013
11. A. S. Hern and ez, "Helper (TH1, TH2, TH17) and regulatory cells (Treg, TH3, NKT) in rheumatoid arthritis, "Reumatologia Clinica Suplementos, vol. 5, supplement 1, pp. 1-5, 2009
12. L. Yang, D. E. and erson, C. Baecher-Allan et al., "IL-21 and TGF-xy are required for differentiation of human Txy17 cells, "Nature, vol. 454, no. 7202, pp. 350-352, 2008
13. C. Gu, L. Wu, and X. Li, "IL-17 family: cytokines, receptors and signaling, "Cytokine, vol. 64, no. 2, pp. 477-485, 2013
14. S. L. Gaffen, "An overview of IL-17 function and signaling, "Cytokine, vol. 43, no. 3, pp. 402-407, 2008
15. S. H. Chang and C. Dong, "Signaling of interleukin-17 family cytokines in immunity and inflammation, "Cellular Signalling, vol. 23, no. 7, pp. 1069-1075, 2011
16. S. H. Chang, J. M. Reynolds, B. P. Pappu, G. Chen, G. J. Martinez, and C. Dong, "Interleukin-17C promotes Th17 cell responses and autoimmune disease via interleukin-17 receptor E, "Immunity, vol. 35, no. 4, pp. 611-621, 2011
17. X. Song and Y. Qian, "IL-17 family cytokines mediated signaling in the pathogenesis of inflammatory diseases, "Cellular Signalling, vol. 25, no. 12, pp. 2335-2347, 2013
18. T. O'SulliVan, R. Saddawi-Konefka, E. Gross et al., "Interleukin-17D mediates tumor rejection through recruitment of natural killer cells, "Cell Reports, vol. 7, no. 4, pp. 989-998, 2014
19. P. Miossec and J. K. Kolls, "Targeting IL-17 and T H 17 cells in chronic inflammation, "Nature Reviews Drug Discovery, vol. 11, no. 10, pp. 763-776, 2012
20. J. M. Reynolds, P. Angkasekwinai, and C. Dong, "IL-17 family member cytokines: regulation and function in innate immunity, "Cytokine and Growth Factor Reviews, vol. 21, no. 6, pp. 413-423, 2010
21. Y. Iwakura, H. Ishigame, S. Saijo, and S. Nakae, "Functional specialization of interleukin-17 familymembers, "Immunity, vol. 34, no. 2, pp. 149-162, 2011
22. F. D'Acquisto, F. Maione, and M. PeDerzoli-Ribeil, "From IL-15 to IL-33: the never-ending list of new players in inflammation. Is it time to forget the humble aspirin and move ahead?"Biochemical Pharmacology, vol. 79, no. 4, pp. 525-534, 2010
23. F. Maione, N. Paschalidis, N. Mascolo, N. Dufton, M. Perretti, and F. D'Acquisto, "Interleukin 17 sustains rather than induces inflammation, "Biochemical Pharmacology, vol. 77, no. 5, pp. 878-887, 2009
24. F. Maione, C. Cicala, E. Liverani, N. Mascolo, M. Perretti, and F. D'Acquisto, "IL-17A increases ADP-induced platelet aggregation, "Biochemical and Biophysical Research Communications, vol. 408, no. 4, pp. 658-662, 2011
25. F. Maione, A. Parisi, E. Caiazzo et al., "Interleukin-17A exacerbates ferric chloride-induced arterial thrombosis in rat carotid artery, "International Journal of Inflammation, vol. 2014, Article ID247503, 6 pages, 2014
26. C. E. Sutton, S. J. Lalor, C. M. Sweeney, C. F. Brereton, E. C. Lavelle, and K. H. G. Mills, "Interleukin-1 and IL-23 induce innate IL-17 production from xyxy T cells, amplifying Th17 responses and autoimmunity, "Immunity, vol. 31, no. 2, pp. 331-341, 2009
27. K. Geddes, S. J. Rubino, J. G. Magalhaes et al., "Identification of an innate T helper type 17 response to intestinal bacterial pathogens, "Nature Medicine, vol. 17, no. 7, pp. 837-844, 2011
28. S. Zhu, W. Pan, X. Song et al., "The microRNA miR-23b suppresses IL-17-associated autoimmune inflammation by targeting TAB2, TAB3 and IKK-xy, "Nature Medicine, vol. 18, no. 7, pp. 1077-1086, 2012
29. C. Wang, L. Wu, K. Bulek et al., "The psoriasis-associated D10N variant of the adaptor Act1 with impaired regulation by the molecular chaperone hsp90, "Nature Immunology, vol. 14, no. 1, pp. 72-81, 2013
30. J. Krstic and J. F. Santibanez, "Transforming growth factorbeta and matrix metalloproteinases: functional interactions in tumor stroma-infiltrating myeloid cells, "The Scientific World Journal, vol. 2014, Article ID 521754, 14 pages, 2014
31. A.W. Ho and S. L. Gaffen, "IL-17RC:Apartner in IL-17 signaling and beyond, "Seminars in Immunopathology, vol. 32, no. 1, pp. 33-42, 2010
32. K. Ghoreschi, A. Laurence, X. Yang et al., "Generation of pathogenic TH17 cells in the absence of TGF-xy signalling, "Nature, vol. 467, no. 7318, pp. 967-971, 2010
33. J. L. Coombes, K. R. R. Siddiqui, C. V. Arancibia-Carcamo et al., "A functionally specialized population of mucosal CD103+ DCs induces Foxp3+ regulatory T cells via a TGF-xy-and retinoic acid-dependentmechanism, "Journal of ExperimentalMedicine, vol. 204, no. 8, pp. 1757-1764, 2007
34. E. Bettelli, Y. Carrier, W. Gao et al., "Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells, "Nature, vol. 441, no. 7090, pp. 235-238, 2006
35. W. J. Leonard, R. Zeng, and R. Spolski, "Interleukin 21: a cytokine/cytokine receptor system that has come of age, "Journal of Leukocyte Biology, vol. 84, no. 2, pp. 348-356, 2008
36. R. Spolski and W. J. Leonard, "The Yin and Yang of interleukin-21 in allergy, autoimmunity and cancer, "Current Opinion in Immunology, vol. 20, no. 3, pp. 295-301, 2008
37. G. Monteleone, F. Pallone, and T. T. MacDonald, "Interleukin-21: a critical regulator of the balance between effector and regulatory T-cell responses, "Trends in Immunology, vol. 29, no. 6, pp. 290-294, 2008
38. Z. Wu, H. P. Kim, H. H. Xue, H. Liu, K. Zhao, and W. J. Leonard, "Interleukin-21 receptor gene induction in human T cells is mediated by T-cell receptor-induced Sp1 activity, "Molecular and Cellular Biology, vol. 25, no. 22, pp. 9741-9752, 2005
39. P. J. Morrison, S. J. Ballantyne, and M. C. Kullberg, "Interleukin-23 and T helper 17-type responses in intestinal inflammation: from cytokines to T-cell plasticity, "Immunology, vol. 133, no. 4, pp. 397-408, 2011
40. M. A. Lowes, C. B. Russell, D. A. Martin, J. E. Towne, and J. G. Krueger, "The IL-23/T17 pathogenic axis in psoriasis is amplified by keratinocyte responses, "Trends in Immunology, vol. 34, no. 4, pp. 174-181, 2013
41. C. Parham, M. Chirica, J. Timans et al., "A receptor for the heterodimeric cytokine IL-23 is composed of IL-12Rxy1 and a novel cytokine receptor subunit, IL-23R, "Journal of Immunology, vol. 168, no. 11, pp. 5699-5708, 2002
42. G. R. Yannam, T. Gutti, and L. Y. Poluektova, "IL-23 in infections, inflammation, autoimmunity and cancer: possible role in HIV-1 and AIDS, "Journal of Neuroimmune Pharmacology, vol. 7, no. 1, pp. 95-112, 2012
43. L. Zhou, I. I. IVanov, R. Spolski et al., "IL-6 programs Txy-17 cell differentiation by promoting sequential engagement of the IL-21 and IL-23 pathways, "Nature Immunology, vol. 8, no. 9, pp. 967-974, 2007
44. N. P. Singh, U. P. Singh, B. Singh, R. L. Price, M. Nagarkatti, and P. S. Nagarkatti, "Activation of Aryl hydrocarbon receptor (AhR) leads to reciprocal epigenetic regulation of Foxp3 and IL-17 expression and amelioration of experimental colitis, "PLoS ONE, vol. 6, no. 8, Article ID e23522, 2011
45. Y. Iwakura and H. Ishigame, "The IL-23/IL-17 axis in inflammation, "Journal of Clinical Investigation, vol. 116, no. 5, pp. 1218-1222, 2006
46. V. Dardalhon, T. Korn, V. K. Kuchroo, and A. C. and erson, "Role of Th1 and Th17 cells in organ-specific autoimmunity, "Journal of Autoimmunity, vol. 31, no. 3, pp. 252-256, 2008
47. M. Paladugu, A. Thakur, L. G. Lum, S. Mittal, and P. Parajuli, "Generation and immunologic functions ofTh17 cells inmalignant gliomas, "Cancer Immunology, Immunotherapy, vol. 62, no. 1, pp. 75-86, 2013
48. G. Cantini, F. Pisati, A. Mastropietro et al., "A critical role for regulatory T cells in driving cytokine profiles of Th17 cells and their modulation of glioma microenvironment, "Cancer Immunology, Immunotherapy, vol. 60, no. 12, pp. 1739-1750, 2011
49. M. Doroudchi, Z. G. Pishe, M. Malekzadeh, H. Golmoghaddam, M. Taghipour, and A. GhaDeri, "Elevated serum IL-17A but not IL-6 in glioma versus meningioma and schwannoma, "Asian Pacific Journal of Cancer Prevention, vol. 14, no. 9, pp. 5225-5230, 2013
50. D. Li, W. Cai, R. Gu et al., "Th17 cell plays a role in the pathogenesis of Hashimoto's thyroiditis in patients, "Clinical Immunology, vol. 149, no. 3, pp. 411-420, 2013
51. R. M. Ruggeri, S. Saitta, M. Cristani et al., "Serum interleukin-23 (IL-23) is increased in Hashimoto's thyroiditis, "Endocrine Journal, vol. 61, no. 4, pp. 359-363, 2014
52. N. Figueroa-Vega, M. Alfonso-Perez, I. Benedicto, F. Sanchez-Madrid, R. Gonzalez-Amaro, and M. Marazuela, "Increased circulating pro-inflammatory cytokines and Th17 lymphocytes in Hashimoto's thyroiditis, "Journal of Clinical Endocrinology and Metabolism, vol. 95, no. 2, pp. 953-962, 2010
53. H. Guo, D. Peng, X. G. Yang et al., "A higher frequency of circulating IL-22+CD4+ T cells in Chinese patients with newly diagnosed Hashimoto's thyroiditis, "PLoS ONE, vol. 9, no. 1, Article ID e84545, 2014
54. S. Wang, S. E. Baidoo, Y. Liu et al., "T cell-Derived leptin contributes to increased frequency of T helper type 17 cells in female patients with Hashimoto's thyroiditis, "Clinical and Experimental Immunology, vol. 171, no. 1, pp. 63-68, 2013
55. A. Bossowski, M. Moniuszko, E. Idzkowska et al., "Evaluation of CD4+CD161+CD196+ and CD4+IL-17+ Th17 cells in the peripheral blood of young patientswithHashimoto's thyroiditis and Grave's disease, "Pediatric Endocrinology, Diabetes, and Metabolism, vol. 18, no. 3, pp. 89-95, 2012
56. Q. Qin, P. Liu, L. Liu et al., "Theincreased but non-predominant expression of Th17-and Th1-specific cytokines in hashimoto's thyroiditis but not in graves' disease, "Brazilian Journal of Medical and Biological Research, vol. 45, no. 12, pp. 1202-1208, 2012
57. L. Zhang, T. Wang, X. Q. Wang et al., "Elevated frequencies of circulating Th22 cell in addition to Th17 cell and Th17/Th1 cell in patients with acute coronary syndrome, "PLoS ONE, vol. 8, no. 12, Article ID e71466, 2013
58. D. C. Newcomb, M. G. Boswell, W. Zhou et al., "Human TH17 cells express a functional IL-13 receptor and IL-13 attenuates IL-17A production, "Journal of Allergy and Clinical Immunology, vol. 127, no. 4, pp. 1006.e1-1013.e4, 2011
59. M. Khojasteh-Fard, M. Abolhalaj, P. Amiri et al., "IL-23 gene expression in PBMCs of patients with coronary artery disease, "Disease Markers, vol. 33, no. 6, pp. 289-293, 2012
60. Z. Liu, F. Lu, H. Pan et al., "Correlation of peripheralTh17 cells and Th17-associated cytokines to the severity of carotid artery plaque and its clinical implication, "Atherosclerosis, vol. 221, no. 1, pp. 232-241, 2012
61. O. J. de Boer, J. J. Van Der Meer, P. Teeling et al., "Differential expression of interleukin-17 family cytokines in intact and complicated human atherosclerotic plaques, "Journal of Pathology, vol. 220, no. 4, pp. 499-508, 2010
62. Z. Liu, Y. Zhao, F. Wei et al., "Treatment with telmisartan/rosuvastatin combination has a beneficial synergistic effect on ameliorating Th17/Treg functional imbalance in hypertensive patients with carotid atherosclerosis, "Atherosclerosis, vol. 233, no. 1, pp. 291-299, 2014
63. Z. Mengya, M. Hanyou, L. Dong, L. Xiaohong, and Z. Lihua, "Th17/Treg imbalance induced by increased incidence of atherosclerosis in patients with Systemic Lupus Erythematosus (SLE), "Clinical Rheumatology, vol. 32, no. 7, pp. 1045-1052, 2013
64. X. H. Yu, N. Jiang, X. L. Zheng, F. S. Cayabyab, Z. B. Tang, and C. K. Tang, "Interleukin-17A in lipid metabolism and atherosclerosis, "Clinica Chimica Acta, vol. 431, pp. 33-39, 2014
65. A. Jamshidian, V. Shaygannejad, A. Pourazar, S. Zarkesh, and M. Gharagozloo, "Biased Treg/Th17 balance away from regulatory toward inflammatory phenotype in relapsed multiple sclerosis and its correlation with severity of symptoms, "Journal of Neuroimmunology, vol. 262, no. 1-2, pp. 106-112, 2013
66. G. Esendagli, A. T. Kurne, G. Sayat, A. K. Kilic, D. Guc, and R. Karabudak, "Evaluation ofTh17-related cytokines and receptors in multiple sclerosis patients unDer interferon beta-1 therapy, "Journal of Neuroimmunology, vol. 255, no. 1-2, pp. 81-84, 2013
67. V. Brucklacher-WalDert, K. Stuerner, M. Kolster, J. Wolthausen, and E. Tolosa, "Phenotypical and functional characterization of T helper 17 cells in multiple sclerosis, "Brain, vol. 132, no. 12, pp. 3329-3341, 2009
68. Y. Li, H. Wang, Y. Long, Z. Lu, and X. Hu, "Increasedmemory Th17 cells in patients with neuromyelitis optica and multiple sclerosis, "Journal of Neuroimmunology, vol. 234, no. 1-2, pp. 155-160, 2011
69. C. J. Hedegaard, M. Krakauer, K. Bendtzen, H. Lund, F. Sellebjerg, and C. H. Nielsen, "T helper cell type 1 (Th1), Th2 and Th17 responses to myelin basic protein and disease activity in multiple sclerosis, "Immunology, vol. 125, no. 2, pp. 161-169, 2008
70. D. Vargas-Lowy, P. Kivisakk, R. Gandhi et al., "Increased Th17 response to myelin peptides in pediatric MS, "Clinical Immunology, vol. 146, no. 3, pp. 176-184, 2013
71. O. Aravena, B. Pesce, L. Soto et al., "Anti-TNF therapy in patients with rheumatoid arthritis decreases Th1 and Th17 cell populations and exp and s IFN-xy-producing NK cell and regulatory T cell subsets, "Immunobiology, vol. 216, no. 12, pp. 1256-1263, 2011
72. D. K. Sato, I. Nakashima, A. Bar-Or et al., "Changes in Th17 and regulatory T cells after fingolimod initiation to treat multiple sclerosis, "Journal of Neuroimmunology, vol. 268, no. 1-2, pp. 95-98, 2014
73. C. M. Sweeney, R. Lonergan, S. A. Basdeo et al., "IL-27mediates the response to IFN-xy therapy in multiple sclerosis patients by inhibitingTh17 cells, "Brain, Behavior, and Immunity, vol. 25, no. 6, pp. 1170-1181, 2011
74. M. Ryba-Stanisawowska, M. Skrzypkowska, M. MySliwiec, and J. MySliwska, "Loss of the balance between CD4+Foxp3+ regulatory T cells and CD4+IL17A+Th17 cells in patients with type 1 diabetes, "Human Immunology, vol. 74, no. 6, pp. 701-707, 2013
75. M. Ryba-Stanisawowska, M. Skrzypkowska, M. MySliwiec, and J. MySliwska, "Loss of the balance between CD4+Foxp3+ regulatory T cells and CD4+IL17A+ Th17 cells in patients with type 1 diabetes, "Human Immunology, vol. 74, no. 6, pp. 701-707, 2013
76. C. Zhang, C. Xiao, P. Wang et al., "The alteration of Th1/Th2/Th17/Treg paradigm in patients with type 2 diabetes mellitus: relationship with diabetic nephropathy, "Human Immunology, vol. 75, no. 4, pp. 289-296, 2014
77. M. Sumarac-Dumanovic, D. Jeremic, A. Pantovic et al., "Therapeutic improvement of glucoregulation in newly diagnosed type 2 diabetes patients is associated with a reduction of IL-17 levels, "Immunobiology, vol. 218, no. 8, pp. 1113-1118, 2013
78. A. Paradowska-Gorycka, A. Grzybowska-Kowalczyk, E. Wojtecka-Lukasik, and S. Maslinski, "IL-23 in the pathogenesis of rheumatoid arthritis, "Scandinavian Journal of Immunology, vol. 71, no. 3, pp. 134-145, 2010
79. C. L. Hickman-Brecks, J. L. Racz, D. M. Meyer, T. P. LaBranche, and P. M. Allen, "Th17 cells can provide B cell help in autoantibody induced arthritis, "Journal of Autoimmunity, vol. 36, no. 1, pp. 65-75, 2011
80. Y. J. Heo, Y. B. Joo, H. J. Oh et al., "IL-10 suppresses Th17 cells and promotes regulatory T cells in the CD4+ T cell population of rheumatoid arthritis patients, "Immunology Letters, vol. 127, no. 2, pp. 150-156, 2010
81. G. Zizzo, M. de Santis, S. L. Bosello et al., "Synovial fluid-Derived T helper 17 cells correlatewith inflammatory activity in arthritis, irrespectively of diagnosis, "Clinical Immunology, vol. 138, no. 1, pp. 107-116, 2011
82. L. Estrada-Capetillo, B. Hern and ez-Castro, A. Monsivais-Urenda et al., "Induction of Th17 lymphocytes and Treg cells by monocyte-Derived dendritic cells in patients with rheumatoid arthritis and systemic lupus erythematosus, "Clinical and Developmental Immunology, vol. 2013, Article ID 584303, 9 pages, 2013
83. X. Niu, D. He, X. Zhang et al., "IL-21 regulates Th17 cells in rheumatoid arthritis, "Human Immunology, vol. 71, no. 4, pp. 334-341, 2010
84. L. Zhang, Y.-G. Li, L.-H. Qi et al., "Increased frequencies of th22 cells as well as th17 cells in the peripheral blood of patients with ankylosing spondylitis and rheumatoid arthritis, "PLoS ONE, vol. 7, no. 4, Article IDe31000, 2012
85. M. Ehrenfeld, "Spondyloarthropathies, "Best Practice and Research: Clinical Rheumatology, vol. 26, no. 1, pp. 135-145, 2012
86. J. A. Smith and R. A. Colbert, "Review: the interleukin-23/interleukin-17 axis in spondyloarthritis pathogenesis: Th17 and beyond, "Arthritis &Rheumatology, vol. 66, no. 2, pp. 231-241, 2014
87. L. Xueyi, C. Lina, W. Zhenbiao, H. Qing, L. Qiang, and P. Zhu, "Levels of circulating Th17 cells and regulatory T cells in ankylosing spondylitis patients with an inadequate response to anti-TNF-xy therapy, "Journal of Clinical Immunology, vol. 33, no. 1, pp. 151-161, 2013
88. T. and ersen, T. K. Rasmussen, M. Hvid et al., "Increasedplasma levels of IL-21 and IL-23 in spondyloarthritis are not associated with clinical and MRI findings, "Rheumatology International, vol. 32, no. 2, pp. 387-393, 2012
89. W. Chen, Y. Chang, K. Lin et al., "Association of serum interleukin-17 and interleukin-23 levels with disease activity in Chinese patients with ankylosing spondylitis, "Journal of the Chinese Medical Association, vol. 75, no. 7, pp. 303-308, 2012
90. L. Melis, B. Vandooren, E. Kruithof et al., "Systemic levels of IL-23 are strongly associated with disease activity in rheumatoid arthritis but not spondyloarthritis, "Annals of the Rheumatic Diseases, vol. 69, no. 3, pp. 618-623, 2010
91. M. Bautista-Caro, I. Arroyo-villa, C. Castillo-gallego et al., "Decreased Th17 and Th1 cells in the peripheral blood of patients with early non-radiographic axial spondyloarthritis: A marker of disease activity in HLA-B27+ patients, "Rheumatology, vol. 52, no. 2, Article IDkes267, pp. 352-362, 2013
92. H. Benham, P. Norris, J. Goodall et al., "Th17 and Th22 cells in psoriatic arthritis and psoriasis, "Arthritis Research &Therapy, vol. 15, no. 5, p. R136, 2013
93. S. Dolff, M. Bijl, M. G. Huitema, P. C. Limburg, C. G. M. Kallenberg, and W. H. Abdulahad, "Disturbed Th1, Th2, Th17 and Treg balance in patients with systemic lupus erythematosus, "Clinical Immunology, vol. 141, no. 2, pp. 197-204, 2011
94. E. A. Elewa, O. Zakaria, E. I. Mohamed, and G. Boghdadi, "The role of interleukins 4, 17 and interferon gamma as biomarkers in patients with Systemic Lupus Erythematosus and their correlation with disease activity, "The Egyptian Rheumatologist, vol. 36, no. 1, pp. 21-27, 2014
95. C. K. Wong, L. C. W. Lit, L. S. Tam, E. K. M. Li, P. T. Y. Wong, and C. W. K. Lam, "Hyperproduction of IL-23 and IL-17 in patients with systemic lupus erythematosus: implications for Th17-mediated inflammation in auto-immunity, "Clinical Immunology, vol. 127, no. 3, pp. 385-393, 2008
96. A. Henriques, L. Ines, M. Couto et al., "Frequency and functional activity of Th17, Tc17 and other T-cell subsets in Systemic Lupus Erythematosus, "Cellular Immunology, vol. 264, no. 1, pp. 97-103, 2010
97. J. Yang, Y. Chu, X. Yang et al., "Th17 and natural treg cell population dynamics in systemic lupus erythematosus, "Arthritis and Rheumatism, vol. 60, no. 5, pp. 1472-1483, 2009
98. K. Vincze, Z. Kovats, A. Cseh et al., "Peripheral CD4+ cell prevalence and pleuropulmonary manifestations in systemic lupus erythematosus patients, "Respiratory Medicine, vol. 108, no. 5, pp. 766-774, 2014
99. X. Yang, H. Wang, X. Zhao, L. Wang, Q. Lv, and Q. Wang, "Th22, but not Th17 might be a good index to predict the tissue involvement of systemic lupus erythematosus, "Journal of Clinical Immunology, vol. 33, no. 4, pp. 767-774, 2013
100. K. Shah, W. Lee, S. Lee et al., "Dysregulated balance ofTh17 and Th1 cells in systemic lupus erythematosus, "Arthritis Research and Therapy, vol. 12, no. 2, article no. R53, 2010
101. W. Kleczynska, B. Jakiela, H. Plutecka, M. Milewski, M. Sanak, and J. Musial, "Imbalance between Th17 and regulatory Tcells in systemic lupus erythematosus, "Folia Histochemica et Cytobiologica, vol. 49, no. 4, pp. 646-653, 2011
102. B. Wang, H. Su, J. Cui, and J. Li, "Elevated Th17 cells are accompanied by FoxP3+ Treg cells decrease in patients with lupus nephritis, "Rheumatology International, vol. 32, no. 4, pp. 949-958, 2012
103. L. Zhang, X. Yang, J. Cheng, R. Hui, and T. Gao, "IncreasedTh17 cells are accompanied by FoxP3+ Treg cell accumulation and correlated with psoriasis disease severity, "Clinical Immunology, vol. 135, no. 1, pp. 108-117, 2010
104. J. B. Golden, T. S. McCormick, and N. L. Ward, "IL-17 in psoriasis: implications for therapy and cardiovascular co-morbidities, "Cytokine, vol. 62, no. 2, pp. 195-201, 2013
105. C. W. Lynde, Y. Poulin, R. VenDer, M. Bourcier, and S. Khalil, "Interleukin 17A: toward a new unDerst and ing of psoriasis pathogenesis, "Journal of the American Academy of Dermatology, vol. 71, no. 1, pp. 141-150, 2014
106. A. Michalak-Stoma, J. Bartosinska, M. Kowal, M. Juszkiewicz-Borowiec, A. Gerkowicz, and G. Chodorowska, "Serumlevels of selected Th17 and Th22 cytokines in psoriatic patients, "Disease Markers, vol. 35, no. 6, pp. 625-631, 2013
107. S. Kagami, H. L. Rizzo, J. J. Lee, Y. Koguchi, and A. Blauvelt, "CirculatingTh17, Th22, and Th1 cells are increased in psoriasis, "Journal of Investigative Dermatology, vol. 130, no. 5, pp. 1373-1383, 2010
108. A. Settesoldi, M. Coppola, F. Rogai, and V. Annese, "Ustekinumab: moving the target from psoriasis to Crohn's disease, "Expert Review of Gastroenterology and Hepatology, vol. 8, no. 1, pp. 5-13, 2014
109. C. Q. F. Wang, A. E. Cruz-Inigo, J. Fuentes-Duculan et al., "Th17 cells and activated dendritic cells are increased in vitiligo lesions, "PLoS ONE, vol. 6, no. 4, Article ID e18907, 2011
110. J. R. Cerhan, W. Liu-Mares, Z. S. FreDericksen et al., "Genetic variation in tumor necrosis factor and the nuclear factor-xyB canonical pathway and risk of non-Hodgkin's lymphoma, "Cancer Epidemiology Biomarkers and Prevention, vol. 17, no. 11, pp. 3161-3169, 2008
111. M. A. Elela, R. A. Hegazy, M. M. Fawzy, L. A. Rashed, and H. Rasheed, "Interleukin 17, interleukin 22 and FoxP3 expression in tissue and serumof non-segmental vitiligo: a casecontrolled study on eighty-four patients, "European Journal of Dermatology, vol. 23, no. 3, pp. 350-355, 2013
112. R. A. Hegazy, M. M. Fawzy, H. I. Gawdat, N. Samir, and L. A. Rashed, "T helper 17 and Tregs: a novel proposed mechanism for NB-UVB in vitiligo, "Experimental Dermatology, vol. 23, no. 4, pp. 283-286, 2014
113. S. Ono, H. Tanizaki, A. Otsuka et al., "Coexistent skin lesions of vitiligo and psoriasis vulgaris. Immunohistochemical analyses for IL-17A-producing cells and regulatory T cells, "Acta Dermato-Venereologica, vol. 94, no. 3, pp. 329-330, 2014
114. S. I. Siakavellas and G. Bamias, "Role of the IL-23/IL-17 axis in Crohn's disease, "Discovery Medicine, vol. 14, no. 77, pp. 253-262, 2012
115. K. Fransen, S. Van Sommeren, H. J. Westra et al., "Correlation of genetic risk and messenger RNA expression in a Th17/IL23 pathway analysis in inflammatory bowel disease, "Inflammatory Bowel Diseases, vol. 20, no. 5, pp. 777-782, 2014
116. H. Rafa, H. Saoula, M. Belkhelfa et al., "IL-23/IL-17A axis correlates with the nitric oxide pathway in inflammatory bowel disease: Immunomodulatory effect of retinoic acid, "Journal of Interferon and Cytokine Research, vol. 33, no. 7, pp. 355-368, 2013
117. A. Ueno, H. Jijon, R. Chan et al., "Increased prevalence of circulating novel IL-17 secreting Foxp3 expressing CD4+ T cells and defective suppressive function of circulating Foxp3+ regulatory cells support plasticity betweenTh17 and regulatory T cells in inflammatory bowel disease patients, "Inflammatory Bowel Diseases, vol. 19, no. 12, pp. 2522-2534, 2013
118. T. Olsen, R. Rismo, G. Cui, R. Goll, I. Christiansen, and J. Florholmen, "TH1 and TH17 interactions in untreated inflamed mucosa of inflammatory bowel disease, and their potential to mediate the inflammation, "Cytokine, vol. 56, no. 3, pp. 633-640, 2011
119. K. Chao, S. Zhang, J. Yao et al., "Imbalances of CD4+ Tcell subgroups in Crohn's disease and their relationship with disease activity and prognosis, "Journal of Gastroenterology and Hepatology, 2014
120. H. Ding, J. Yang, J. Yang, J. Ding, P. Chen, and P. Zhu, "Interleukin-17 contributes to cardiovascular diseases, "Molecular Biology Reports, vol. 39, no. 7, pp. 7473-7478, 2012
121. R. X. Zhao, W. J. Li, Y. R. Lu et al., "Increased peripheral proinflammatory T helper subsets contribute to cardiovascular complications in diabetic patients, "Mediators of Inflammation, vol. 2014, Article ID596967, 12 pages, 2014
122. C. Danyan, H. Xiaolong, L. Song, G. Hua, T. Weixue, and L. Ke, "The effects of rhBMP-2 and Treg/Th17 functional disequilibrium in uremic patients with cardiovascular complication after maintenance hemodialysis, "International Journal of Artificial Organs, vol. 36, no. 7, pp. 464-472, 2013
123. J. Zhang, G. Hua, X. Zhang, R. Tong, X. Du, and Z. Li, "Regulatory T cells/T-helper cell 17 functional imbalance in uraemic patients on maintenance haemodialysis: a pivotal link between microinflammation and adverse cardiovascular events: original Article, "Nephrology, vol. 15, no. 1, pp. 33-41, 2010
124. M. Salgado, N. I. Rallon, B. Rodes, M. Lopez, V. Soriano, and J. M. Benito, "Long-term non-progressors display a greater number of Th17 cells than HIV-infected typical progressors, "Clinical Immunology, vol. 139, no. 2, pp. 110-114, 2011
125. Y. Alvarez, M. Tuen, Nadas, and C. E. Hioe, "In vitro restoration of Th17 response during HIV infection with an antiretroviral drug and Th17 differentiation cytokines, "AIDS Research and Human Retroviruses, vol. 28, no. 8, pp. 823-834, 2012
126. Y. He, J. Li, Y. Zheng et al., "Ar and omized case-control study of dynamic changes in peripheral bloodTh17/Treg cell balance and interleukin-17 levels in highly active antiretroviral-treated HIV type 1/AIDS patients, "AIDS Research and Human Retroviruses, vol. 28, no. 4, pp. 339-345, 2012
127. A. Singh, M. Vajpayee, S. A. Ali, K. Mojumdar, N. K. Chauhan, and R. Singh, "HIV-1 diseases progression associated with loss of Th17 cells in subtype "C"infection, "Cytokine, vol. 60, no. 1, pp. 55-63, 2012
128. M. F. Chevalier, G. Petitjean, C. Dunyach-Remy et al., "The Th17/Treg ratio, IL-1RA and sCD14 levels in primary HIV infection predict the T-cell activation set point in the absence of systemic microbial translocation, "PLoS Pathogens, vol. 9, no. 6, Article ID e1003453, 2013
129. D. Li, J. Chen, M. Jia et al., "Loss of balance between T helper type 17 and regulatory T cells in chronic human immunodeficiency virus infection, "Clinical and Experimental Immunology, vol. 165, no. 3, pp. 363-371, 2011
130. C. J. Kim, L. R. McKinnon, C. Kovacs et al., "Mucosal Th17 cell function is altered during HIV infection and is an independent predictor of systemic immune activation, "The Journal of Immunology, vol. 191, no. 5, pp. 2164-2173, 2013
131. L. Brandt, T. Benfield, H. Mens et al., "Low level of regulatory T cells and maintenance of balance between regulatory T cells and TH17 cells in HIV-1-infected elite controllers, "Journal of Acquired Immune Deficiency Syndromes, vol. 57, no. 2, pp. 101-108, 2011
132. A. G. Rowan, J. M. Fletcher, E. J. Ryan et al., "Hepatitis C virus-specific Th17 cells are suppressed by virus-induced TGF-xy, "Journal of Immunology, vol. 181, no. 7, pp. 4485-4494, 2008
133. A. Fathy, A. S. Ahmed, L. Metwally, and A. Hassan, "T helper type 1/T helper type 17-related cytokines in chronic hepatitis C patients before and after interferon and ribavirin therapy, "Medical Principles and Practice, vol. 20, no. 4, pp. 345-349, 2011
134. G. M. Sousa, I. S. Oliveira, L. J. O. and rade, M. L. B. Sousa-Atta, R. Parana, and A.M. Atta, "Serum levels ofTh17 associated cytokines in chronic hepatitis C virus infection, "Cytokine, vol. 60, no. 1, pp. 138-142, 2012
135. R. G. Foster, L. Golden-Mason, A. Rutebemberwa, and H. R. Rosen, "Interleukin (IL)-17/IL-22-producing T cells enriched within the liver of patients with chronic hepatitis C viral (HCV) infection, "Digestive Diseases and Sciences, vol. 57, no. 2, pp. 381-389, 2012
136. M. A. Jimenez-Sousa, R. Almansa, C. de La Fuente et al., "IncreasedTh1, Th17 and pro-fibrotic responses in hepatitis Cinfected patients are down-regulated after 12 weeks of treatment with pegylated interferon plus ribavirin, "European Cytokine Network, vol. 21, no. 2, pp. 84-91, 2010
137. Q. Wang, J. Zhou, B. Zhang et al., "Hepatitis B virus induces IL-23 production in antigen presenting cells and causes liver damage via the IL-23/IL-17 axis, "PLoS Pathogens, vol. 9, no. 6, Article ID e1003410, 2013
138. B. Yang, Y. Wang, C. Zhao et al., "Increased Th17 cells and interleukin-17 contribute to immune activation and disease aggravation in patients with chronic hepatitis B virus infection, "Immunology Letters, vol. 149, no. 1-2, pp. 41-49, 2013
139. J. Li, J. Shi, W. Ren, W. Wu, and Z. Chen, "Regulatory role of CD4(+)CD25(+)Foxp3(+) regulatory T cells on IL-17-secreting T cells in chronic hepatitis B patients, "Digestive Diseases and Sciences, vol. 59, no. 7, pp. 1475-1483, 2014
140. S. Zhu, H. Zhang, Y. Dong et al., "The correlation between T helper type 17 cells and clinical characters in Chinese paediatric patients with chronic hepatitis B, "Clinical and Experimental Immunology, vol. 171, no. 3, pp. 307-312, 2013
141. L. Wang, Q. Meng, Z. Zou et al., "Increased frequency of circulating Th17 cells in acute-on-chronic hepatitis B liver failure, "Digestive Diseases and Sciences, vol. 57, no. 3, pp. 667-674, 2012
142. H. Q. Sun, J. Y. Zhang, H. Zhang, Z. S. Zou, F. S. Wang, and J. H. Jia, "Increased Th17 cells contribute to disease progression in patients with HBV-associated liver cirrhosis, "Journal of Viral Hepatitis, vol. 19, no. 6, pp. 396-403, 2012
143. L. Xue-Song, L. Cheng-Zhong, Z. Ying, and W. Mo-Bin, "Changes of Treg and Th17 cells balance in the development of acute and chronic hepatitis B virus infection, "BMC Gastroenterology, vol. 12, article no. 43, 2012
144. J. Li, S. J. Qiu, W. She et al., "Significance of the balance between regulatory T (Treg) and T helper 17 (Th17) cells during hepatitis B virus related liver fibrosis, "PLoS ONE, vol. 7, no. 6, Article ID e39307, 2012
145. G. Zhang, D. Xie, B. Lin et al., "Imbalance of interleukin-17-producing CD4 T cells/regulatory T cells axis occurs in remission stage of patients with hepatitis B virus-related acuteon-chronic liver failure, "Journal of Gastroenterology and Hepatology, vol. 28, no. 3, pp. 513-521, 2013
146. Y. H. Niu, D. L. Yin, H. L. Liu et al., "Restoring the Treg cell to Th17 cell ratio may alleviate HBVrelated acute-on-chronic liver failure, "World Journal of Gastroenterology, vol. 19, no. 26, pp. 4146-4154, 2013
147. B. Wang, X. Zhao, Y. Fan, J. Zhang, J. Zhao, and K. Wang, "IL-17A but not IL-22 suppresses the replication of hepatitis B virus mediated by over-expression of MxA and OAS mRNA in the HepG2.2.15 cell line, "Antiviral Research, vol. 97, no. 3, pp. 285-292, 2013
148. H. Y. Kim, J. Y. Jhun, M. L. Cho et al., "Interleukin-6 upregulates Th17 response via mTOR/STAT3 pathway in acute-on-chronic hepatitis B liver failure, "Journal of Gastroenterology, 2013
149. J. Li, W. Wu, G. Peng et al., "HBcAg induces interleukin-10 production, inhibiting HBcAg-specific Th17 responses in chronic hepatitis B patients, "Immunology and Cell Biology, vol. 88, no. 8, pp. 834-841, 2010
150. J. M. Wang, C. J. Ma, G. Y. Li et al., "Tim-3 alters the balance of IL-12/IL-23 and drives TH17 cells: role in hepatitis B vaccine failure during hepatitis C infection, "Vaccine, vol. 31, no. 18, pp. 2238-2245, 2013